ATCC  

Manassas,  VA 
United States
https://www.atcc.org/

ATCC provides well-characterized cells and reagents for the exploration of lung, skin, cardiovascular, gastro-enteric, liver, renal, and neural toxicity in either traditional cell-based assays or high-throughput screening. We offer human and animal cell lines, human primary cells, stem cells, hTERT-immortalized primary cells, renal uptake screening tools, cell proliferation assays, and cell authentication test services. Learn more at www.atcc.org/tox.


 Press Releases

  • ATCC to provide more physiologically relevant immuno-oncology tools for better reproducibility and improved in vitro targeting to facilitate the advancement of novel cancer treatments.

    Manassas, VA, United States

    November 03, 2022

    ATCC, the world’s premier biological materials management and standards organization, today announced a new line of products, CAR-T Target luciferase reporter cell lines, that will support immuno-oncology (IO) discovery and development of novel immunotherapies. These models have a high endogenous expression of relevant chimeric antigen receptor (CAR)-T target antigens such as HER2, CD19, and CD20. These new IO tools are comprised of both hematological cancer and solid tumor cell lines that express a luciferase reporter.

    “At ATCC, our mission is to offer the scientific community credible biological products that support incredible achievements in basic science, drug discovery, translational medicine, and public health,” said Raymond H. Cypess, D.V.M., Ph.D., chairman and CEO of ATCC. “We believe that these innovative CAR-T target cell lines will help mitigate some of the formidable roadblocks that IO researchers encounter in their fight against cancer.”

    These new IO tools alleviate many of the challenges in evaluating the ex vivo biofunction of CAR-T cells. Coming from highly authenticated and characterized human ATCC cell lines eliminates questions of cell provenance, as well as potential donor-to-donor and cross-species issues. In addition, these lines stably express a sensitive, robust, and easy-to-use reporter system and have been shown in a recent study to display dose-dependent targeting. 

    “As IO is one of the fastest growing sectors in cancer research and therapeutics, ATCC continues to prioritize the development of solutions to support the global effort in advancing this field,” said Fang Tian, Ph.D., director of Biological Content.

    ATCC supports cancer research and drug discovery with thousands of human and animal cancer cell lines for a better understanding of tumor biology, cancer genomics, tumor biomarkers, and advancing novel therapeutics. In addition to providing the most commonly used historical tumor cell lines, ATCC develops genetically engineered cell lines, tumor organoids, reporter cell lines, and drug-resistant cell lines for the global scientific community. 

    ATCC will be showcasing its immuno-oncology research tools at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting in Boston, Massachusetts, November 8 through November 12, 2022. At booth 313, they will present the poster, “Luciferase reporter cancer cell lines facilitate CAR-T development.”

    About ATCC

    ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government. With a history of scientific contributions spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological reference materials and data, and is a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, partnerships, and people provide the global scientific community with credible, advanced, model systems to support complex research and innovations in basic science, drug discovery, translational medicine, and public health. ATCC is a 501(c)3 nonprofit organization with headquarters in Manassas, Virginia, and a research and technology center of excellence in Gaithersburg, Maryland. 

    Contact: Kim Testa, senior director, Corporate Communications & Public Affairs, ATCC, pr@atcc.org


 Products

  • Cell Authentication
    ATCC offers testing services for authenticating human and mouse cell lines by STR and detecting mycoplasma....

  • ATCC has the world’s largest and most extensive product catalog of human and animal cell lines for research purposes. The cell biology collection includes more than 5,000 continuous cell lines available by species, tissue/disease types, and molecular signatures.  ATCC offers convenient and affordable Cell Authentication testing kits for Human STR, Mouse STR and Mycoplasma detection. Human STR testing allows one to establish a DNA fingerprint or confirm your cell line identity. Mouse STR assay validates the authenticity of mouse cell lines and detects contamination by human and African green monkey DNA. To help you detect or rule out mycoplasma contamination of your cell cultures quickly, ATCC offers two different mycoplasma testing services to choose from: PCR-based mycoplasma testing, which is rapid and sensitive, and culture-based mycoplasma testing, which is also sensitive and includes both direct and indirect culture methods that are based on the Food and Drug Administration's Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals.

  • ATCC Biorepository
    ATCC provides researchers with cGMP-compliant biorepository services that enable the secure and reliable storage and management of your precious biological materials....

  • Your research depends on reliable biomaterials that you can trust. That means ensuring that the quality and authenticity of your material remains consistent throughout each stage of your project. With nearly a century of experience in biomaterials services and management, we have the expertise needed to authenticate, store, maintain, and globally distribute biological samples. By entrusting ATCC with your samples, you can rest assured that your materials are securely managed through a temperature-controlled supply chain, and 24/7 equipment monitoring. We’ll take care of the logistics and resources, so you can focus on what’s important—your research. Some things to consider about biomaterials storage services: Would you rather spend your budget on securing your cells or on infrastructure and people to develop more drugs? Would you rather ship the materials yourself or outsource the process to a trusted partner?  By trusting ATCC, you can avoid time and labor intensive in-house measures and eliminate associated risks and costs. Our longevity in the industry and reputation for stringent quality controls gives you the confidence that your drug development efforts will be fully supported.

  • hTERT-immortalized Cells
    Human telomerase reverse transcriptase (hTERT)–immortalized primary cells are a breakthrough that combines the in vivo nature of primary cells with the traditional cell line's ability to survive continuously in vitro....

  • ATCC genetically modified human primary cells so they exhibit the growth characteristics of a continuous cell line with extended proliferative capacity yet maintain the physiology of a primary cell. ATCC cells, media, and reagents allow you to investigate renal, neural, airway, and skin toxicity for such applications as high-content screening, 3-D culture, spheroid culture, permeability assays, metabolic stability and survival studies, transport activity measurement, and more.

    ATCC hTERT-immortalized primary cells include:

    Aortic endothelial cells

    Barrett’s esophageal epithelial cells

    Bronchial epithelial cells

    Respiratory epithelial cells

    Chrondrocyte fibroblast cells

    Dermal microvascular endothelial cells (including TIME cells)

    Dermal melanocytes

    Endometrial fibroblast cells

    Foreskin keratinocytes

    Lung endothelial cells

    Mammary epithelial cells

    Mesenchymal stem cells

    NTAP Schwann cells

    Pancreas duct cells

    Prostrate cells

    Renal epithelial cells

    Retinal pigmented epithelial cells

    Skin fibroblast cells

  • Human iPS Cells
    ATCC has developed a growing portfolio of complete solution systems for successful Human Induced Pluripotent Stem Cell culture and experiments....

  • Human somatic cells can be genetically reprogrammed to become embryonic stem cell-like by introducing combinations of specific genes. The versatility to create patient-specific iPSC lines and the ability to culture and differentiate them to a specific lineage gives the cells great potential for developmental and tissue differentiation studies, epigenetics, disease-modeling, drug development, and regenerative medicine. In vitro propagation and maintenance of these cells in an undifferentiated state is essential. ATCC offers Human iPSCs derived from fibroblasts isolated from the skin, liver, and heart of normal tissue donors and donors with Parkinson’s disease, Down syndrome, or cystic fibrosis. These iPSCs have been reprogrammed by the episomal plasmid, retroviral, or Sendai viral expression of OCT4, SOX2, KLF4, and MYC genes. ATCC also offers CD34+ iPSCs derived from bone marrow of normal tissue donors of various ethnicities and reprogrammed by Sendai viral expression. To culture these cells, ATCC Stem Cell Media, Kits, and Reagents are specially formulated for growth, dissociation, cryopreservation, and differentiation.
  • IPSC derived cells
    ATCC IPSC derived Neural progenitor cells (NPCs) are valuable for investigators looking to reduce the time from initial iPSC culture through differentiation to experiment readout, as they eliminate the 4 to 8 weeks for iPSCs to differentiate...

  • Neural progenitor cells (NPCs) are potent models of normal and disease neurobiology and cell-based neurological therapy development and testing. NPC solutions from ATCC are a complete system for investigating development, degeneration and regeneration, neurogenetics, neural excitability, nervous system disorders, neurotransmitters, and screening therapeutics. We offer normal and Parkinson’s disease iPSC-derived NPCs. Additionally, we offer gene-edited, lineage specific reporter NPCs. ATCC NPCs are derived from a collection of well characterized, integration-free reprogrammed iPSCs. The single donor state of the parental line ensures reduced variation between experiments. Other advantages of ATCC authenticated NPCs include, easy endpoint readout, >80% post-thaw cell viability and post-thaw cell viability >1x106/vial. The cells also exhibit longevity >15 PDLs or 5 passages. The marker expression is Nestin and Pax 6 positive, Tra-I-60 negative. The cells are sterility tested and are negative for bacteria, yeast, fungi, mycoplasma with no viruses detected. The neuronal differentiation potential is >70% Tuj1+ early neurons and >10% dopaminergic neurons.

  • Primary Cells
    Primary cell cultures more closely mimic the physiological state of cells in vivo. Primary cultures consist of cells that have been freshly derived from a living organism....

  • As scientists, we are challenged to identify the adverse effects of a broad range of substances to protect people and the environment. It is critical that the standards and model organisms used in toxicological testing are reliable and authenticated. ATCC provides primary cell cultures that toxicologists need to perform standardized, reliable, and reproducible toxicology studies. Primary cultures are cells freshly isolated from organ tissue and maintained for growth in vitro. Epithelial cells, fibroblasts, keratinocytes, melanocytes, endothelial cells, muscle cells, hematopoietic cells, and mesenchymal stem cells are the cell types most frequently used in research. Human primary cells are commonly used in vitro for preclinical and investigative biological research, such as studies of intercellular and intracellular communication, developmental biology, and the mechanisms seen in cancer, Parkinson’s disease, and diabetes. Human primary cells derived from particular tissues and maintained with the appropriate primary cell culture media and supplements now represent a more advanced model for recapitulating that tissue cell type.


Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".


Copyright © 2022 American College of Toxicology. All rights reserved.
You may view the ACT Privacy Policy, Code of Conduct, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication.
Privacy Policy | Code of Conduct | Provide Consent | Unsubscribe